Building AI-ready Cultures in Life Sciences R&D
Life sciences are over‑funding AI and under‑funding the data maturity required to scale it. This imbalance is turning a potential R&D accelerant into a high‑priced bottleneck that fails to deliver compounding returns across the portfolio. These workflows depend on fragmented…






